首頁 > 市場調查報告書 > 醫療設備

體外診斷

藥物濫用檢測市場規模、佔有率和成長分析（按產品類型、檢體類型、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900441

藥物濫用檢測市場規模、佔有率和成長分析（按產品類型、檢體類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Drug of Abuse Testing Market Size, Share, and Growth Analysis, By Product Type (Analyzers, Rapid Testing Devices), By Sample Type (Saliva, Breath), By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球藥物濫用檢測市場規模預計在 2024 年達到 40.2 億美元，從 2025 年的 42.5 億美元成長到 2033 年的 66.8 億美元，在預測期（2026-2033 年）內複合年成長率為 5.8%。

受藥物濫用日益猖獗、行業監管日益嚴格以及人們對藥物檢測在醫療保健和職場場所重要性認知不斷提高的推動，全球藥物濫用檢測市場正經歷強勁成長。政府為促進合規和意識提升而採取的舉措，顯著推動了對打擊藥物濫用檢測服務的需求。非法藥物生產和販運的增加進一步凸顯了檢測服務的必要性。然而，諸如檢測某些物質微量成分的局限性以及不斷變化的藥物合法化法律可能帶來的影響等挑戰，都對市場動態構成風險。儘管存在這些障礙，檢測技術的創新以及藥物篩檢與醫療保健服務的融合，為市場擴張提供了巨大的機會。

全球藥物濫用檢測市場促進因素

新型毒品和非法毒品的生產、消費和分銷的增加是推動藥物濫用檢測（DoA）需求成長的關鍵因素，從而促進了市場發展。吸毒者的高發生率凸顯了對有效藥物濫用檢測解決方案的迫切需求，推動了該產業的發展。此外，政府旨在意識提升並促進組織內部合規性的舉措預計也將支持市場擴張。同時，對具有更高特異性和靈敏度的合成藥物檢測產品的需求不斷成長，進一步鞏固了藥物濫用檢測市場的成長。

限制全球藥物濫用檢測市場的因素

全球藥物濫用檢測市場面臨許多可能阻礙其成長潛力的重大障礙。其中一個主要問題是現有檢測產品無法有效檢測某些藥物的微量成分。此外，旨在將娛樂性藥物和非法藥物合法化的立法不斷變化，也為市場擴張帶來了額外的挑戰。對該市場進行全面評估，可以深入了解近期發展、法律規範、貿易趨勢、價值鏈效率、競爭格局、新興機會和技術進步等方面的關鍵資訊。對於希望在不斷變化的藥物檢測領域中把握未來成長機會的相關人員而言，了解這些因素至關重要。

全球藥物濫用檢測市場趨勢

全球藥物濫用檢測市場正顯著轉向更廣泛地採用就地檢驗解決方案。這一趨勢凸顯了對快速且方便的藥物檢測方法日益成長的需求，這些方法可在各種非實驗室環境中進行，例如診所、職場和偏遠地區。即時檢測結果的便利性滿足了人們對及時介入日益成長的需求，尤其是在緊急情況和職業健康領域。隨著相關人員優先考慮效率和柔軟性，檢測技術的創新正在進一步加速這一趨勢，並塑造藥物濫用檢測解決方案的未來。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）

結論與建議

簡介目錄

Product Code: SQMIG35H2250

Global Drug of Abuse Testing Market size was valued at USD 4.02 Billion in 2024 and is poised to grow from USD 4.25 Billion in 2025 to USD 6.68 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global drug of abuse testing market is witnessing robust growth driven by the rising incidence of substance abuse, strict industry regulations, and heightened awareness of the significance of drug testing in healthcare and workplace environments. A substantial demand for drug testing services is emerging to combat substance abuse, alongside government initiatives promoting compliance and awareness. Increased production and trade of illicit drugs further underscore the necessity for testing services. However, challenges such as limitations in detecting trace amounts of certain substances and the potential impact of evolving drug legalization laws pose risks to market dynamics. Despite these obstacles, innovations in testing technologies and the integration of drug screening with healthcare services present significant opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segments Analysis

Global Drug of Abuse Testing Market is segmented by Product Type, Sample Type, Testing Type, End-user and region. Based on Product Type, the market is segmented into Analyzers, Rapid Testing Devices and Consumables. Based on Sample Type, the market is segmented into Saliva, Breath, Urine, Blood and Hair & Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing. Based on End-user, the market is segmented into Hospitals, Diagnostics Laboratories, On-the-spot Testing and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug of Abuse Testing Market

The increasing production, consumption, and distribution of both new and illicit drugs are significant factors driving the demand for Drug of Abuse (DoA) testing, consequently stimulating market growth. The high prevalence of drug users highlights the urgent need for effective DoA testing solutions, propelling the industry forward. Furthermore, government initiatives designed to raise awareness about drug abuse and promote compliance within organizations are expected to support market expansion. Additionally, there is a rising demand for testing products that provide enhanced specificity and sensitivity in detecting designer drugs, which further strengthens the growth of the Drug of Abuse testing market.

Restraints in the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is encountering significant obstacles that may hinder its growth potential. One primary concern is the inadequacy of existing testing products, which struggle to effectively detect minute quantities of certain drugs. Furthermore, the ongoing shifts in legislation aimed at legalizing recreational and illicit substances present additional challenges for market expansion. Comprehensive assessments of the market reveal crucial insights into recent advancements, regulatory frameworks, trade dynamics, value chain efficiency, competitive landscape, emerging opportunities, and technological progressions. Addressing these factors is essential for stakeholders looking to navigate the evolving environment of drug testing and capitalize on future growth prospects.

Market Trends of the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is witnessing a pronounced shift towards the increasing adoption of point-of-care testing solutions. This trend highlights a growing demand for rapid and accessible drug testing methods that can be conducted in various non-laboratory environments, including clinics, workplaces, and remote locations. The convenience and immediacy of obtaining test results at the point of care cater to the rising need for timely interventions, particularly in emergency and occupational health contexts. As stakeholders prioritize efficiency and flexibility, innovations in testing technology are further propelling this movement, shaping the future landscape of drug abuse testing solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Drug of Abuse Testing Market Size by Product Type & CAGR (2026-2033)

Market Overview
Analyzers
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
Consumables
- Fluid Collection Devices
- Others

Global Drug of Abuse Testing Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Saliva
Breath
Urine
Blood
Hair & Sweat

Global Drug of Abuse Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Medical Screening
Monitoring Pain Management
Forensic & Legal Information
Employment Drug Testing
Sports & Athletics Testing

Global Drug of Abuse Testing Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostics Laboratories
On-the-spot Testing
Forensic Laboratories

Global Drug of Abuse Testing Market Size & CAGR (2026-2033)

North America (Product Type, Sample Type, Application, End-user)
- US
- Canada
Europe (Product Type, Sample Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Sample Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Sample Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Sample Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments